Seung Kook Park

USPTO Granted Patents = 13 (Patent Applications = 8)

EPO Patents = 5 (Patent Applications = 9)

Average Co-Inventor Count = 4.6

ph-index = 3

Forward Citations = 32(Granted Patents)

Location History:

Kyungki-Do, KR (1992)
Gyeonggi-do, KR (2010)
Seongnam-si, KR (2013)
Seoul, KR (1996 - 2023)

Company Filing History:

8 out of 27

Hanall Biopharma Co., Ltd.

Goldstar Electron Co., Ltd.

where one patent can have more than one assignee

Years Active: 1992-2023

Loading Chart...

13 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11613578 - Antibody binding to FCRN for treating autoimmune diseases (2023-03-28),

2. 10544226 - Antibody binding to FcRn for treating autoimmune diseases (2020-01-28),

3. 10336825 - Antibody binding to FcRn for treating autoimmune diseases (2019-07-02),

4. 10280207 - FcRn-specific human antibody and composition for treatment of autoimmune diseases (2019-05-07),

5. 9580490 - Uses of modified human tumor necrosis factor receptor-1 polypeptide (2017-02-28),

6. 9068019 - Modified human tumor necrosis factor receptor-1 polypeptide or fragment thereof, and method for preparing same (2015-06-30),

7. 8895500 - Modified human tumor necrosis factor receptor-I polypeptide or fragment thereof, and method for preparing same (2014-11-25),

8. 8754037 - Modified human tumor necrosis factor receptor-1 polypeptide or fragment thereof, and method for preparing same (2014-06-17),

9. 8685440 - Nanoliposome using esterified lecithin and method for preparing the same, and composition for preventing or treating skin diseases comprising the same (2014-04-01),

10. 8409586 - Stable liquid formulation of human growth hormone (2013-04-02),

11. 7811786 - Preparation method for the production of active and soluble proteins in prokaryotes and polycistronic vectors therefor (2010-10-12),

12. 5532579 - Temperature stabilized low reference voltage generator (1996-07-02),

13. 5166583 - Driving methods and driving circuits for brushless DC motors without (1992-11-24),

Title: Innovations of Seung Kook Park

Introduction

Seung Kook Park is a prominent inventor based in Seoul, South Korea. He has made significant contributions to the field of biotechnology, particularly in the development of antibodies for treating autoimmune diseases. With a total of 13 patents to his name, Park's work has the potential to impact many lives.

Latest Patents

One of his latest patents involves an isolated anti-FcRn antibody. This antibody binds to the neonatal Fc receptor (FcRn), which has a high affinity for immunoglobulin G (IgG) or its fragments. The patent describes a method of preparing this antibody, a composition for treating autoimmune diseases that includes the antibody, and methods for treating and diagnosing these diseases. The FcRn-specific antibody binds to FcRn non-competitively with IgG, effectively reducing serum pathogenic auto-antibody levels. This innovative approach can be utilized for the treatment of various autoimmune diseases.

Career Highlights

Seung Kook Park has worked with notable companies in the biotechnology sector, including Hanall Biopharma Co., Ltd. and Daewoong Co., Ltd. His experience in these organizations has contributed to his expertise in antibody development and therapeutic applications.

Collaborations

Throughout his career, Park has collaborated with talented individuals such as Sung Wuk Kim and Jae Kap Jeong. These partnerships have fostered innovation and advancement in his research endeavors.

Conclusion

Seung Kook Park's contributions to the field of biotechnology, particularly through his innovative patents, highlight his role as a leading inventor in the treatment of autoimmune diseases. His work continues to pave the way for new therapeutic options and improved patient outcomes.

This text is generated by artificial intelligence and may not be accurate.